CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUE
Should you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.
Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.
In the previous week, Centene had 9 more articles in the media than Elevance Health. MarketBeat recorded 20 mentions for Centene and 11 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.91 beat Centene's score of 0.56 indicating that Elevance Health is being referred to more favorably in the news media.
Centene currently has a consensus price target of $85.23, suggesting a potential upside of 17.20%. Elevance Health has a consensus price target of $587.42, suggesting a potential upside of 13.14%. Given Centene's higher probable upside, analysts clearly believe Centene is more favorable than Elevance Health.
Centene received 181 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.25% of users gave Centene an outperform vote while only 66.67% of users gave Elevance Health an outperform vote.
Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.
Centene has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.
93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.3% of Centene shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Elevance Health has a net margin of 3.64% compared to Centene's net margin of 1.76%. Elevance Health's return on equity of 20.62% beat Centene's return on equity.
Summary
Elevance Health beats Centene on 12 of the 17 factors compared between the two stocks.
Get Centene News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
